Targeting Microbiota 2019 - Preliminary Agenda

Session 1: Microbiota 2019: Recent Advances & Challenges

Metabolic and Metagenomic Consequences of E. coli Infections
Matteo Serino, Inserm and Digestive Health Research Institute, France

Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Agata Mulak, Wroclaw Medical University, Poland

Risk for Diabetes and Cardiovascular diseases in the Qatari population: Can the salivary microbiome predict it?
Souhaila Al Khodor, Sidra Medical and Research Center, Qatar

Session 2: Challenges of microbiota-host cross-talk understanding and intestinal microbiome signaling to extraintestinal organs

Session 3: Microbiota Metabolites and Metabolome: Challenges & Perspectives

Gut bacterial metabolites as markers and mediators of cardiovascular aging
Marcin Ufnal, Medical University of Warsaw, Poland

Targeting Microbiota Dinner

Special Workshop: Skin microbiota 2019: From basics to applied cosmetics and skin care

Florence Abdallah, University Paris-Sud - Inserm U 1184, France

The first part
Skin Microbiota : Recent advances and perspectives

The second part
Strategies to modulate and affect skin microbiota in health and diseases?

Dialogue between the skin and the microbiota: The immune system is under control
Chantal Pichon, French National Centre for Scientific Research, France

Intestinal barrier, gut microbiota and psoriasis
Mariusz Sikora, Medical University of Warsaw, Poland

Session 4:  Session on Built Environment Microbiome

Special session on Built Environment Microbiome
Markus Egert, Furtwangen University, Germany

International Space Station and hospital environments: Composition and function of microbiomes in confined built environments
Moissl-Eichinger, Medical University Graz, Austria

Modulating the microbiota of the hospital environment by probiotic cleaning: impact on infections and antimicrobial resistance
Elisabetta Caselli, University of Ferrara, Italy

Session 5: Microbiota & medicine of tomorrow: Development of effective therapeutic strategies to manipulate the gut microbiota

Gut microbiota and graft-versus-host disease in patients after bone marrow transplantation.
FMT as a prevention or treatment?
Jaroslaw Bilinski, Medical University of Warsaw, Poland

microRNA in host-microbiome interaction and probiotics
Elena M Comelli, University of Toronto, Canada

Hyaluronan, a new neuroimmune modulator of the microbiota-immune-gut-axis
Cristina Giaroni, University of Insubria, Italy

Short Oral Presentations

General Discussion & Concluding Remarks: Microbiota, big data and artificial intelligency: we need to initiate the discussion.

Targeting Microbiota Awards